These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6779331)

  • 21. Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
    Andén NE; Engel J
    Adv Neurol; 1974; 5():317-24. PubMed ID: 4613158
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of electroconvulsive shock on central cholinergic (muscarinic) receptors.
    Gulati A; Nath C; Dhawan KN; Bhargava KP; Agarwal AK; Seth PK
    Brain Res; 1982 May; 240(2):357-8. PubMed ID: 7104697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive and noradrenaline-depleting effects of alpha-methyl-5-hydroxytryptophan in the rat.
    Tabei R; Spector S; Louis WJ; Sjoerdsma A
    Eur J Pharmacol; 1969 Jul; 7(1):39-44. PubMed ID: 5307150
    [No Abstract]   [Full Text] [Related]  

  • 24. Repeated electroconvulsive shock attenuates clonidine-induced hypoactivity in rodents.
    Heal DJ; Akagi H; Bowdler JM; Green AR
    Eur J Pharmacol; 1981 Nov; 75(4):231-7. PubMed ID: 7318908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of the L-5-hydroxytryptophan-induced elevation of plasma corticosterone levels in rats by a specific inhibitor of serotonin uptake.
    Fuller RW; Snoddy HD; Molloy BB
    Res Commun Chem Pathol Pharmacol; 1975 Jan; 10(1):193-6. PubMed ID: 1079087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central transmitter involvement in LON-954-induced tremorogenesis.
    Coward DM; Doggett NS; Thomas JE
    Neuropharmacology; 1977; 16(7-8):479-84. PubMed ID: 144244
    [No Abstract]   [Full Text] [Related]  

  • 27. Experimental data suggesting an adrenergic mechanism in the production of parkinsonian symptoms.
    Silvestrini B; Lisciani R
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):716-24. PubMed ID: 136334
    [No Abstract]   [Full Text] [Related]  

  • 28. The influence of L-triiodothyronine (T3) on the effects of repeated administration of desipramine or electroconvulsive shock on alpha 2- and beta-adrenoceptor function in the brain of the rat: implications for the potentiation of antidepressant therapy by T3.
    Heal DJ; Bristow LJ; Elliott JM; Bloomfield JG; Catto LC; Atterwill CK
    Neuropharmacology; 1987 Aug; 26(8):1131-9. PubMed ID: 2821441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypophysectomy does not prevent the enhanced monoamine-mediated behavioural responses following repeated electroconvulsive shocks.
    Nutt DJ; Smith SL; Heal DJ
    Neuropharmacology; 1982 Sep; 21(9):881-4. PubMed ID: 7145040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the antinociceptive activities of physostigmine, oxotremorine and morphine in the mouse.
    Pleuvry BJ; Tobias MA
    Br J Pharmacol; 1971 Dec; 43(4):706-14. PubMed ID: 4261560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weight gain in young Mongolian gerbils (Meriones unguiculatus) of mothers treated with neurotropic substances, hypoxia or electroconvulsive shock.
    Blösch M
    Physiol Behav; 1981 Sep; 27(3):425-9. PubMed ID: 7335783
    [No Abstract]   [Full Text] [Related]  

  • 32. Serotonin regulation of corticoid secretion in infant rats.
    Grota LJ
    Dev Psychobiol; 1981 May; 14(3):221-8. PubMed ID: 6973496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of dihydroxyphenylserine on the increase in plasma corticosterone in rats treated with alpha-methyl-p-tyrosine.
    Cuello AC; Scapagnini U; Licko V; Preziosi P; Ganong WF
    Neuroendocrinology; 1973-1974; 13(1):115-22. PubMed ID: 4779044
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence for selective inhibition of sympathetic outflow by oxotremorine.
    Baum T; Becker FT
    Eur J Pharmacol; 1980 Jun; 64(2-3):199-202. PubMed ID: 7398765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasopressin antagonizes retrograde amnesia in rats following electroconvulsive shock.
    Pfeifer WD; Bookin HB
    Pharmacol Biochem Behav; 1978 Aug; 9(2):261-3. PubMed ID: 568802
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanism of prolactin release by 5-hydroxytryptophan.
    Takahara J; Yamauchi J; Niimi M; Kageyama J; Aoki Y; Fujino K; Hashimoto K; Ofuji T
    Life Sci; 1981 Oct; 29(14):1463-6. PubMed ID: 6975410
    [No Abstract]   [Full Text] [Related]  

  • 37. Increased sensitivity to serotonergic agonists after repeated electroconvulsive shock in rats.
    Wielosz M
    Pharmacol Biochem Behav; 1985 May; 22(5):683-7. PubMed ID: 2989938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased shock sensitivity in rats with experimental allergic encephalomyelitis and reversal by 5-hydroxytryptophan.
    White SR; White FP; Barnes CD; Albright JF
    Brain Res; 1973 Aug; 58(1):251-4. PubMed ID: 4354376
    [No Abstract]   [Full Text] [Related]  

  • 39. An attempt to explain differences in the hypophyseal-adrenocortical response to repeated stressful stimuli by their dependence on differences in pathways.
    Stark E; Fachet J; Makara GB; Mihály K
    Acta Med Acad Sci Hung; 1968; 25(2):251-60. PubMed ID: 5732213
    [No Abstract]   [Full Text] [Related]  

  • 40. Lithium-induced hypersensitivity to foot shock in rats and the role of 5-hydroxytryptophan.
    Harrison-Read PE; Steinberg H
    Nat New Biol; 1971 Jul; 232(30):120-1. PubMed ID: 5315100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.